Cipla reappoints Umang Vohra as MD, Global CEO

Published On 2021-03-24 07:19 GMT   |   Update On 2021-03-24 07:19 GMT
Advertisement

New Delhi: Pharma major Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.

The board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as ''Managing Director and Global Chief Executive Officer'' of the company, for a further period of five years w.e.f. April 1, 2021 to March 31, 2026, Cipla said in a regulatory filing.

Advertisement

Vohra had joined Cipla in 2015 and has been the MD & Global CEO of the company since September 1, 2016, it added.

Read also: Cipla to support Terra Carta, for sustainable future

"As Cipla''s MD & GCEO, Vohra''s priorities have been Cipla''s strategic growth, defining and executing Cipla''s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation," the filing said.

After gaining degrees in engineering, marketing and finance, Vohra worked with Eicher Motors, PepsiCo and Dr Reddy''s Laboratories, it added.


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News